Protocol: ROP1 - Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity
Status: Closed
Start Date: 04/28/2015
End Date: 05/11/2021
Clinical Trial ID: NCT02390531
Public Dataset:  


Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity?

Protocol
Injection Procedure manual

 

Primary Objective:

  • The primary objective of the study is to determine a dose of a single intravitreal bevacizumab injection that is effective and is lower than currently used for treatment of severe (type 1) ROP.



Back